Table 1 Clinicopathologic characteristics of miR-29b expression in NSCLC patients

Age

>60

14

46.67

−2.044 ± 1.311

= < 60

16

53.33

−1.807 ± 0.989

0.578

Gender

Male

16

53.33

−1.883 ± 0.722

Female

14

46.67

−1.957 ± 1.508

0.862

Histology

Squamous cancer

4

13.33

−2.182 ± 0.858

Adenocarcinoma

26

86.67

−1.877 ± 1.182

0.625

Differentiation

Well + Moderate

21

70

−1.931 ± 1.344

Poor

9

30

−1.886 ± 0.401

0.891

Clinic Stage

I

10

33.33

−1.122 ± 0.638

II

9

30

−1.881 ± 0.453

III

11

36.67

−2.671 ± 1.398

0.004

Lymphatic Metastasis

No

16

53.33

−1.505 ± 0.799

Yes

14

46.67

−2.389 ± 1.302

0.031